Literature DB >> 35538393

GPCR Intracellular Loop Regulation of Beta-Arrestin-Mediated Endosomal Signaling Dynamics.

Jianing Li1, Jacob M Remington2, Chenyi Liao2, Rodney L Parsons3, Severin Schneebeli2, Karen M Braas3, Victor May4, Matthias Brewer2.   

Abstract

G protein-coupled receptors (GPCRs) are currently appreciated to be routed to diverse cellular platforms to generate both G protein-dependent and -independent signals. The latter has been best studied with respect to β-arrestin-associated receptor internalization and trafficking to signaling endosomes for extracellular signal-regulated kinase (ERK) activation. However, how GPCR structural and conformational variants regulate endosomal ERK signaling dynamics, which can be central in neural development, plasticity, and disease processes, is not well understood. Among class B GPCRs, the PACAP-selective PAC1 receptor is unique in the expression of variants that can contain intracellular loop 3 (ICL3) cassette inserts. The nervous system expresses preferentially the PAC1Null (no insert) and PAC1Hop (28-amino acid Hop insert) receptor variants. Our molecular modeling and signaling studies revealed that the PAC1Null and PAC1Hop receptor variants can associate with β-arrestin differentially, resulting in enhanced receptor internalization and ERK activation for the PAC1Hop variant. The study amplifies our understandings of GPCR intracellular loop structure/function relationships with the first example of how the duration of endosomal ERK activation can be guided by ICL3. The results provide a framework for how changes in GPCR variant expression can impact developmental and homeostatic processes and may be contributory to maladaptive neuroplasticity underlying chronic pain and stress-related disorders.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  ERK activation; GPCR endosomal signaling; PAC1 receptor; Stress-related disorders; β-arrestin

Mesh:

Substances:

Year:  2022        PMID: 35538393      PMCID: PMC9311399          DOI: 10.1007/s12031-022-02016-8

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   2.866


  94 in total

1.  Region-specific effects of acute and repeated restraint stress on the phosphorylation of mitogen-activated protein kinases.

Authors:  Emanuel Meller; Changpeng Shen; Talia A Nikolao; Catrin Jensen; Yelena Tsimberg; Jingyuan Chen; Rand J Gruen
Journal:  Brain Res       Date:  2003-07-25       Impact factor: 3.252

2.  Structure of an arrestin2-clathrin complex reveals a novel clathrin binding domain that modulates receptor trafficking.

Authors:  Dong Soo Kang; Ronald C Kern; Manojkumar A Puthenveedu; Mark von Zastrow; John C Williams; Jeffrey L Benovic
Journal:  J Biol Chem       Date:  2009-08-25       Impact factor: 5.157

Review 3.  Endosome maturation, transport and functions.

Authors:  Cameron C Scott; Fabrizio Vacca; Jean Gruenberg
Journal:  Semin Cell Dev Biol       Date:  2014-04-04       Impact factor: 7.727

4.  Proteinase-activated receptor 2 sensitizes transient receptor potential vanilloid 1, transient receptor potential vanilloid 4, and transient receptor potential ankyrin 1 in paclitaxel-induced neuropathic pain.

Authors:  Y Chen; C Yang; Z J Wang
Journal:  Neuroscience       Date:  2011-07-14       Impact factor: 3.590

Review 5.  β-Arrestin-mediated receptor trafficking and signal transduction.

Authors:  Sudha K Shenoy; Robert J Lefkowitz
Journal:  Trends Pharmacol Sci       Date:  2011-06-15       Impact factor: 14.819

6.  Structure-based discovery of opioid analgesics with reduced side effects.

Authors:  Aashish Manglik; Henry Lin; Dipendra K Aryal; John D McCorvy; Daniela Dengler; Gregory Corder; Anat Levit; Ralf C Kling; Viachaslau Bernat; Harald Hübner; Xi-Ping Huang; Maria F Sassano; Patrick M Giguère; Stefan Löber; Grégory Scherrer; Brian K Kobilka; Peter Gmeiner; Bryan L Roth; Brian K Shoichet
Journal:  Nature       Date:  2016-08-17       Impact factor: 49.962

7.  Alternative splicing in the N-terminal extracellular domain of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor modulates receptor selectivity and relative potencies of PACAP-27 and PACAP-38 in phospholipase C activation.

Authors:  C Pantaloni; P Brabet; B Bilanges; A Dumuis; S Houssami; D Spengler; J Bockaert; L Journot
Journal:  J Biol Chem       Date:  1996-09-06       Impact factor: 5.157

8.  Parabrachial Pituitary Adenylate Cyclase-Activating Polypeptide Activation of Amygdala Endosomal Extracellular Signal-Regulated Kinase Signaling Regulates the Emotional Component of Pain.

Authors:  Galen Missig; Linda Mei; Margaret A Vizzard; Karen M Braas; James A Waschek; Kerry J Ressler; Sayamwong E Hammack; Victor May
Journal:  Biol Psychiatry       Date:  2016-08-29       Impact factor: 13.382

9.  Activation of ERK2 in basolateral amygdala underlies the promoting influence of stress on fear memory and anxiety: influence of midazolam pretreatment.

Authors:  N M Maldonado; P J Espejo; I D Martijena; V A Molina
Journal:  Eur Neuropsychopharmacol       Date:  2013-10-18       Impact factor: 4.600

10.  OPM database and PPM web server: resources for positioning of proteins in membranes.

Authors:  Mikhail A Lomize; Irina D Pogozheva; Hyeon Joo; Henry I Mosberg; Andrei L Lomize
Journal:  Nucleic Acids Res       Date:  2011-09-02       Impact factor: 16.971

View more
  2 in total

Review 1.  Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of Receptors.

Authors:  Jessica Lu; Sarah J Piper; Peishen Zhao; Laurence J Miller; Denise Wootten; Patrick M Sexton
Journal:  Int J Mol Sci       Date:  2022-07-22       Impact factor: 6.208

Review 2.  Female reproductive functions of the neuropeptide PACAP.

Authors:  Miklos Koppan; Zsuzsanna Nagy; Inez Bosnyak; Dora Reglodi
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-20       Impact factor: 6.055

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.